News > No need to panic says Serum Institute of India amid concerns over Oxford-AstraZeneca trial error

No need to panic says Serum Institute of India amid concerns over Oxford-AstraZeneca trial error

Amid concerns over the efficacy of Oxford vaccine after pharma major AstraZeneca admitted a dosing error, its India partner Serum Institute of India (SII) said the vaccine candidate is safe and effective and the Indian trials are progressing smoothly with strict adherence to all protocols.

“The AstraZeneca-Oxford vaccine is safe and effective. Even the lowest efficacy results are at 60-70%, making it a viable vaccine against the virus. We must be patient and not panic,” SII said.